Scientist Jailed for Gene Hacking Babies Says Ethics Are Holding Back Progress
By Luis Prada,
Vice
| 03. 14. 2025
public domain photo by Voice of America via Wikimedia Commons
Back in 2019, Chinese biophysicist He Jiankui proudly announced to the world that he had created two genetically edited human babies, fully expecting a round of applause and three cheers of “Hip Hip Hooray.” Instead, everyone booed him and he got thrown in prison for three years.
He’s since been released from prison, though it doesn’t seem like he’s learned any lessons from his stint in the clink. This was demonstrated by a post on Twitter/X wherein he accompanied a soulless picture of himself in a tweet in which he says that “ethics is holding back scientific innovation and progress.”
Now, you might recognize that is the kind of thing a villain says before he splices into your DNA, unforeseen consequences be damned. Jiankui used CRISPR gene-editing technology to edit the DNA of a set of twins codenamed “Nana” and “Lulu” to make them immune to HIV. Sounds like a noble goal, until you find out that fiddling with those genes to make the girls immune to HIV could...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...